Saturday, 4 December 2010

New Child leukaemia drug could boost survival rates


Scientists are hailing a chemotherapy drug found to significantly increase the survival chances of child leukaemia patients whose cancer has returned.

A Cancer Research UK study found giving mitoxantrone to children whose acute lymphoblastic leukaemia returned led to a 69% survival rate after three years.

The standard treatment offers a 45% survival rate, The Lancet study says.

To read the full article on the BBC website click HERE.

No comments: